Tolazoline
Medication Facts
- Performance enhancing
- No
- Total hours to clear
- Not recorded
- Frequently used
- N/A
- ESC ID
- TOLAZO-0877
- Trade names
- Priscoline
- Drug type
- Alpha-2 antagonist
- Plasma half-life · hours
- Not Published
- Equine dosing
- 0.1-0.2 mg/kg IV
- Cmax · peak plasma concentration
- Unknown
- Tmax · time to peak plasma concentration
- Immediate
- ESC concentration guidance
- May not exceed 6% efficacy in plasma
- Primary withdrawal · hours
- 12
- Washout withdrawal · hours
- 0
- ESC control type
- C1 - Strictly Controlled - Restricted - Performance
- Medication report required
- MED REPORT REQUIRED
Uses & side effects
Product-specific side effects await source review.
